Santa Farma Pharma continues to validate its international standards at its manufacturing facility in Kocaeli-GEBKİM. Aligning with its growth targets across the Eurasian Economic Union (EAEU) market, the company completed GMP audit routines performed by the health authorities of Russia and Kazakhstan.
The operational audit across the facility concluded with "non-critical" limited findings, leading to an official "successful" evaluation report and the issuance of GMP certificates from both nations. Having previously secured GMP approvals from Brazilian and Peruvian authorities, Santa Farma demonstrated compliance across cleanroom validation, cross-contamination controls, computerized system integration, documentation discipline, and quality risk management frameworks.
Executive Statement
Evaluating the double international approval, Sami Kiresepi, CEO of Santa Farma Pharma, stated:
Successfully passing these critical audits by Russian and Kazakh health authorities and receiving our GMP certificates is one of the most concrete validations of our vision to make Santa Farma a reliable and strong manufacturer in global markets. At Santa Farma, we do not view international audits merely as compliance checks; we position every single process as a development dynamic that enriches our operational routines. In line with our vision to become a reference company that meets local market needs with global standards, we are pleased to make a value-added contribution to both the Turkish pharmaceutical industry and our country's global export targets.
